# OnCo record ideaya-biosciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ideaya-biosciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ideaya-biosciences" ;
  schema:name "IDEAYA Biosciences"@en ;
  schema:description "IDEAYA Biosciences develops cancer drugs matched to the genetic make-up of a patient's tumour. Its most advanced drug, darovasertib, is in late-stage trials for a rare eye cancer called uveal melanoma."@en ;
  schema:url <https://onco.cc/companies/ideaya-biosciences/>, <https://www.ideayabio.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.ideayabio.com/>, <https://www.ideayabio.com/pipeline/>, <https://www.sec.gov/Archives/edgar/data/1676725/000119312519158427/d746735dex991.htm>, <https://ir.ideayabio.com/news-releases> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/synthetic-lethality-approaches/>, <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/dll3/> ;
  onco:drugs <https://onco.cc/drugs/darovasertib/> ;
  onco:trials <https://onco.cc/trials/nct05987332/>, <https://onco.cc/trials/nct03947385/>, <https://onco.cc/trials/nct05907954/>, <https://onco.cc/trials/nct07174583/>, <https://onco.cc/trials/nct06710847/> .